PFE
Pfizer Inc
DRUG MANUFACTURERS - GENERAL · HEALTHCARE
Pfizer Inc. is a leading global pharmaceutical and biotechnology company headquartered in New York City, boasting a distinguished history of innovation since 1849. With a comprehensive therapeutic portfolio that includes key areas such as immunology, oncology, and cardiology, Pfizer is committed to ...
$27.73
+0.04% (+$0.01)
Volume
28.14M
52W High
$29.21
52W Low
$23.58
Market Cap
$142.66B
What to Watch This Quarter
Based on historical dataConsensus EPS
$0.79
Whisper EPS
$0.86
8.4% above consensus
Last Quarter
$0.77
Current Streak
6 Beats
Avg Surprise (4Q)
+17.82%
Next Earnings Report
Reports in 48 days
Price Chart
EPS History: Consensus vs Actual
Last 10 quartersPrice Movement Around Earnings
Q2 2026
Aug 4, 2026
1-Day:
+1.57%
Q2 2026
Jul 29, 2026
1-Day:
-0.95%
5-Day:
-0.48%
Q1 2026
May 5, 2026
1-Day:
+0.30%
Q1 2026
Apr 28, 2026
1-Day:
-0.83%
Revenue & Financial Performance
Revenue Whisper
$15.08B
TWN Proprietary Estimate
Last Quarter Revenue
$15.03B
+2.6% YoY
Gross Margin
72.8%
Net Margin: -1.6%
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q2'26 | $15.03B | +2.6% | 72.8% | 31.3% | -$246.0M |
| Q1'26 | $14.45B | +5.4% | 67.3% | 27.9% | $2.69B |
| Q4'25 | $17.56B | -1.2% | 70.0% | 21.0% | -$1.65B |
| Q3'25 | $16.65B | -5.9% | 75.0% | 21.3% | $3.54B |
| Q2'25 | $14.65B | +10.3% | 64.3% | 24.4% | $2.91B |
| Q1'25 | $13.72B | -7.8% | 71.7% | 33.7% | $2.97B |
| Q4'24 | $17.76B | +21.9% | 73.0% | 32.2% | $403.0M |
| Q3'24 | $17.70B | +31.2% | 60.9% | 28.1% | $4.47B |
Company Information
Symbol
PFE
Company
Pfizer Inc
Market Cap
$142.66B
Sector
HEALTHCARE
Next Earnings
Nov 3, 2026
Also Reporting Soon
Companies reporting earnings around the same time as PFE
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in DRUG MANUFACTURERS - GENERAL
Compare PFE with competitors
Side-by-side earnings comparison